Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: RTOG 0938 Principal Investigator: Michalski, Jeff
Title: A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Phase: II Disease Site: Prostate
Participating Site(s):
 
Main Campus
Map and Directions
St. Peters
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to compare two methods of delivering high dose radiation to the prostate to see if the effects of the treatments are similar. Both methods have been studied previously and are considered promising treatment approaches. Standard radiation therapy can involve daily treatment for several weeks, often over seven and a half or eight weeks (up to approximately 40 treatments). One of the standard treatment options for your stage and type of prostate cancer is external beam radiation therapy. More recent radiation therapy planning methods such as intensity modulated radiation therapy (IMRT) allow safer delivery of higher than standard daily doses of radiation.
 
More Information:
ClinicalTrials.gov #
Internal Protocol Documents (requires Siteman administrative database password)